An international, Phase III clinical trial led by investigators at Mass General Brigham could improve the treatment of a rare ...

Regeneron’s clinical trials are at the core of this mission. Regeneron is grateful to all clinical trial participants — ...

An experimental vaccine teaching patients’ immune systems to identify and attack cancer cells could help women diagnosed with ...

Top-line data for its phase 2b trial studying GH001 is expected either in the fourth quarter of 2024 or the first quarter of ...

Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, ...

Incorporating Africa into the clinical trial landscape will attract significant investment, create jobs, and boost the local ...

An international, multidisciplinary team of leading neuro-oncology researchers and clinicians has released new ...

At the OCT DACH conference, experts shared how EU laws, digitalisation, and more, are impacting trials in the DACH region and ...

A new drug strategy that regulates the tumor immune microenvironment may transform a tumor that resists immunotherapy into a ...

In Japan, clinical use is climbing faster, with about 4,500 people now on the drug. ARIA rates in Japan are half those in the U.S., which was also the case in the Phase 3 Clarity trial. Meanwhile, use ...

A groundbreaking treatment has been announced for women with an extremely aggressive form of breast cancer. Siteman Cancer ...